Alpha-9 Oncology

Harnessing the power of radiopharmaceuticals

Vancouver, Canada · Founded 2019 · $257.8M raised

Headquarters
Vancouver
Founded
2019
Business Model
B2B
Total Funding
$257.8M
Last Round
$175.0M Series COct 2024
Rounds
4

About

Alpha-9 Oncology is a clinical-stage radiopharmaceutical company advancing a distinctive portfolio of bespoke, targeted molecules to treat cancer cells with unparalleled precision. The company employs an iterative process to optimize each part of the molecule — binder, linker, chelator, and radioisotope — supported by state-of-the-art infrastructure and in-house formulation expertise. Alpha-9 is backed by top-tier investors with Phase 1 studies underway, including A9-3408, an Actinium-225-based radiotherapeutic. Headquartered in Vancouver, BC with a U.S. office in Boston, MA.

Summary

Alpha-9 Oncology is a Life Sciences company based in Vancouver, Canada, founded in 2019. It has raised $257.8M in total across 4 rounds, most recently a $175.0M Series C round in Oct 2024. Investors include Lightspeed Venture Partners, Ascenta Capital and Nextech Invest.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries COct 2024
$175.0M

Sign up to see all 4 rounds

Seed through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alpha-9 Oncology on Indexed.vc
<a href="https://indexed.vc/companies/alpha-9-oncology"><img src="https://indexed.vc/api/badge/company/alpha-9-oncology" alt="Alpha-9 Oncology on Indexed.vc" width="260" height="76" /></a>